EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental Models

Maria De Carluccio, Gabriele Di Sante iD, Maria Elisabetta Clementi iD, Mariangela Ruggirello, Anna Maria Stabile iD, Alessandra Pistilli iD, Stefano Marini, Vincenzo Romano Spica iD, Mario Rende, Francesco Ria iD, Fabrizio Michetti iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26135948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria De Carluccio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy. Hauptthemen laut MEDLINE: S100 Calcium Binding Protein beta Subunit, Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis, Neuroglia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Education - MUR, Italian Ministry of Education, Nando and Elsa Peretti Foundation 2019.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been demonstrated that S100B actively participates in neuroinflammatory processes of different diseases of the central nervous system (CNS), such as experimental autoimmune encephalomyelitis (EAE), a recognized animal model for multiple sclerosis (MS). The inhibition of S100B activity using pentamidine and of S100B synthesis using arundic acid are able to determine an amelioration of the clinical and pathologic parameters of MS with milder and delayed symptoms. This study further goes in detail on the role of S100B, and in particular of astrocytic S100B, in these neuroinflammatory processes. To this aim, we used a model of S100B knockout (KO) mice. As expected, S100B protein levels were significantly reduced in the S100B KO mouse strain resulting in an amelioration of clinical and pathological parameters (clinical and morphological analyses). To dissect the potential mechanisms that could explain the role of S100B in the development of EAE, we sorted, cultured, and compared glial subpopulations (astrocytes, oligodendrocytes, and microglia) derived from S100B KO and wild type mice, through flow cytometric panels and ELISA. Glial cells were analyzed for proinflammatory molecules showing a significant reduction of TNFα protein in mice where S100B was silenced. To dissect the role of S100B in MS, we cultured astrocytes and microglial cells magnetically sorted and enriched from the brains of EAE-affected animals, both from KO and wild type animals. Both genetic silencing of S100B and pharmacological inhibition with S100B-targeting compounds demonstrated a direct impact on specific subpopulations of astrocytes (mainly), oligodendrocytes, and microglia. The present results further individuate astrocytic S100B as a key factor and as a potential therapeutic target for EAE neuroinflammatory processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

S100 Calcium Binding Protein beta SubunitEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisNeurogliaAnimalsMiceMice, KnockoutAstrocytesDisease Models, AnimalMice, Inbred C57BLMicrogliaOligodendrogliaFemaleCells, Cultured

Stichwörter der Autor:innen

S100Barundic acidexperimental autoimmune encephalomyelitismultiple sclerosispentamidine isethionate

Substanzen

S100 Calcium Binding Protein beta SubunitS100b protein, mouse

Autor:innen und Institutionen

  • Department of Neuroscience, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
  • Department of Surgery and Medicine, Institute of Human, Clinical and Forensic Anatomy, P.le L Severi 1, 06132 Perugia, Italy.
  • Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" SCITEC-CNR, Largo F. Vito 1, 00168 Rome, Italy.
  • Department of Translational Medicine and Surgery, Section of General Pathology, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
  • Department of Clinical Sciences and Translational Medicine, Università of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
  • Department of Movement, Human and Health Sciences, Laboratory of Epidemiology and Biotechnologies, University of Rome "Foro Italico", Piazza Lauro De Bosis 6, 00135 Rome, Italy.

ORCID-Profile: Gabriele Di Sante, Maria Elisabetta Clementi, Anna Maria Stabile, Alessandra Pistilli, Vincenzo Romano Spica, Francesco Ria, Fabrizio Michetti

Förderung

  • Italian Ministry of Education - MUR
  • Italian Ministry of Education
  • Nando and Elsa Peretti Foundation 2019
  • FISM-Fondazione Italiana Sclerosi Multipla

Zitieren

APA

De Carluccio, M., Di Sante, G., Clementi, M. E., Ruggirello, M., Stabile, A. M., Pistilli, A., Marini, S., Romano Spica, V., Rende, M., Ria, F., & Michetti, F. (2025). Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135948

Vancouver

De Carluccio M, Di Sante G, Clementi ME, Ruggirello M, Stabile AM, Pistilli A, et al. Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135948

BibTeX
@article{DeCarluccio2025,
  author = {De Carluccio, Maria and Di Sante, Gabriele and Clementi, Maria Elisabetta and Ruggirello, Mariangela and Stabile, Anna Maria and Pistilli, Alessandra and Marini, Stefano and Romano Spica, Vincenzo and Rende, Mario and Ria, Francesco and Michetti, Fabrizio},
  title = {Effect on Different Glial Cell Types of S100B Modulation in Multiple Sclerosis Experimental Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26135948}
}
Kostenlos starten →